Publications by authors named "Herlander Marques"

Claim this Profile
E
Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO.
Gurdeep Parmar, Marcelo Capra, Fernanda Seguro, Vania Hungria, Meletios-Athanasios Dimopoulos, Herlander Marques

Blood Cancer J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel genetic loci for risk of multiple myeloma by functional annotation.
Angelica Macauda, Klara Briem, Alyssa Clay-Gilmour, Wendy Cozen, Asta Försti, Herlander Marques

Leukemia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk.
Marco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, Angelica Macauda, Juan Sainz, Herlander Marques

Int J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating lncRNA- and miRNA-Associated ceRNA Network as a Potential Prognostic Biomarker for Non-Hodgkin Lymphoma: A Bioinformatics Analysis and a Pilot Study.
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros

Biomedicines· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polygenic risk score for multiple myeloma risk prediction.
Federico Canzian, Chiara Piredda, Angelica Macauda, Daria Zawirska, Niels Frost Andersen, Herlander Marques

Eur J Hum Genet· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives.
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros

Biomedicines· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin's Lymphoma: Moving towards an RNA-Guided Precision Medicine.
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ceRNA Network of lncRNA/miRNA as Circulating Prognostic Biomarkers in Non-Hodgkin Lymphomas: Bioinformatic Analysis and Assessment of Their Prognostic Value in an NHL Cohort.
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros

Int J Mol Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions.
Sara Reis Moura, Hugo Abreu, Carla Cunha, Cláudia Ribeiro-Machado, Carla Oliveira, Herlander Marques

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.
Angelica Macauda, Chiara Piredda, Alyssa I Clay-Gilmour, Juan Sainz, Gabriele Buda, Herlander Marques

Int J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common gene variants within 3'-untranslated regions as modulators of multiple myeloma risk and survival.
Ombretta Melaiu, Angelica Macauda, Juan Sainz, Diego Calvetti, Maria Sole Facioni, Herlander Marques

Int J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically determined telomere length and multiple myeloma risk and outcome.
Matteo Giaccherini, Angelica Macauda, Enrico Orciuolo, Marcin Rymko, Karolina Gruenpeter, Herlander Marques

Blood Cancer J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study.
Daniele Campa, Alessandro Martino, Angelica Macauda, Marek Dudziński, Anna Suska, Herlander Marques

Leuk Lymphoma· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
Julieta Afonso, Tatiana Pinto, Susana Simões-Sousa, Fernando Schmitt, Adhemar Longatto-Filho, Herlander Marques

Cell Oncol (Dordr)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma.
Liliana Castro Oliveira, Carlos Fardilha, Manuel Louro, Carlos Pinheiro, Abílio Sousa, Herlander Marques

Ecancermedicalscience· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients.
Angelica Macauda, Eleonora Castelli, Gabriele Buda, Matteo Pelosini, Aleksandra Butrym, Herlander Marques

Br J Haematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracardiac mass from Burkitt's lymphoma in an immunocompromised patient: a very rare form of presentation.
Ana Vilaça, Margarida Monteiro, Teresa Pimentel, Herlander Marques

BMJ Case Rep· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of miRSNPs associated with the risk of multiple myeloma.
Angelica Macauda, Diego Calvetti, Giuseppe Maccari, Kari Hemminki, Asta Försti, Herlander Marques

Int J Cancer· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.
Rafael Ríos-Tamayo, Carmen Belén Lupiañez, Daniele Campa, Thomas Hielscher, Niels Weinhold, Herlander Marques

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methodology for single nucleotide polymorphism selection in promoter regions for clinical use. An example of its applicability.
Herlander Marques, José Freitas, Rui Medeiros, Adhemar Longatto-Filho

Int J Mol Epidemiol Genet· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
Sandra Fernandes Martins, Ricardo Amorim, Marta Viana-Pereira, Céline Pinheiro, Ricardo Filipe Alves Costa, Herlander Marques

BMC Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell leukaemia.
Carlos Galvão Braga, Ana Raquel Rodrigues, Marina Alves, Catarina Portela, Luísa Pinto, Herlander Marques

Porto Biomed J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.
Flavio Mavignier Cárcano, Daniel Onofre Vidal, André van Helvoort Lengert, Cristovam Scapulatempo Neto, Luisa Queiroz, Herlander Marques

Tumour Biol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Elad Ziv, Eric Dean, Donglei Hu, Alessandro Martino, Daniel Serie, Herlander Marques

Nat Commun· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.
Elad Ziv, Eric Dean, Donglei Hu, Alessandro Martino, Daniel Serie, Herlander Marques

Nat Commun· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis